Best Novartis Podcasts (2024)

1
Pharma and Biotech Daily: Novartis Acquires Kate Therapeutics for $1.1 Billion, Eli Lilly Partners with Chinese Biotech, and More 1:04

2h ago1:04

1:04

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.Novartis has recently acquired gene therapy specialist Kate Therapeutics for up to $1.1 billion, as part of its strategy to expand its new modality pipeline. This acquisition aligns with Novartis' goal to tap into the…

1
Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc. 32:11

1d ago32:11

32:11

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc.By Court of Appeals for the Federal Circuit

1
Woman In The Mirror | Healthcare Edition w/Lene Hylling Axelsson, Novo Nordisk; Kalavathi GV, Siemens Healthineers; Mohua Sengupta, Novartis 33:36

9d ago33:36

33:36

Ever wondered what it really takes to lead in healthcare? Not just the strategies and successes, but the quiet moments of doubt, the unexpected triumphs, and the beautiful chaos of balancing it all? In this conversation on Healthcare Leadership, three industry titans take us behind the scenes. Join Zinnov’s CMO, Nitika Goel, as she sits down with t…

1
Empowering In-home Care With PRN Nursing w/ Jasmine Bhatti 39:36

37m ago39:36

39:36

TOPICS (0:20) Introduction (1:05) What Led Jasmine Bhatti to Healthcare (4:00) Going from Nurse to Business Owner (7:58) Looking at the Success of Care Transitions (12:38) The Difference in Home Care Coverage (15:40) The Complexities of Home Care (18:54) The Cost Equation for PRNs (23:43) How to Prevent Readmissions (25:12) Do Health Systems Unders…

1
Pharma and Biotech Daily: From Sage's Disappointing Trials to Novo Nordisk's Promising Data 1:05

1h ago1:05

1:05

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Sage Therapeutics has decided to discontinue the development of a drug for Huntington's disease after disappointing results in Phase II trials. This comes after previous failures in studies for Parkinson's and Alzheimer's…

1
Pharma and Biotech Daily: Lupus Breakthroughs, Drug Discovery Solutions, and Industry Updates 0:57

1d ago0:57

0:57

Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world.Biogen and UCB recently achieved unexpected success with their late-stage trial for dapirolizumab pegol in lupus. This has led to plans for a second trial by the end of the year. At the American College of Rheumatology me…

1
VAXXED: Game on, with BASE and WEHI 26:07

1h ago26:07

26:07

Cancer vaccines are an area that anyone who is anyone is getting into, but it's a field led largely by academics, not-for–profits, and specialist researchers. So this week we go back to basics - science that is. Australia may not have many cancer vaccine biotechs but – as we pointed out in episode one with the godfather of cancer vaccines, professo…

1
Mehrnaz Campbell in converation with Christian Wöckel from Sanofi 48:37

14m ago48:37

48:37

In the next in the Digital Transformation Series, Mehrnaz Campbell will be talking to Christian Wöckel, Head of RSV Franchise @Vaccines Germany & Austria for Sanofi. With a passion for Digital Transformation, and a strong drive for results and impact, Christian has helped different organisations and business units to transform in a world of constan…

1
CRISPR Breakthroughs, WHO's Global Hub, and the Future of Drug Approvals: Pharma and Biotech Daily Update 3:36

40m ago3:36

3:36

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The FDA's accelerated approval pathway, established in 1992 to expedite the approval of drugs for serious conditions, has been under scrutiny due to recent market withdrawals and failed confirmatory trials. Despite these se…

1
Pharma and Biotech Daily: Navigating Uncertainty in the Industry 0:57

1h ago0:57

0:57

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Robert F. Kennedy Jr., known for his anti-vaccine views, has been chosen by President Trump to lead the Department of Health and Human Services. Kennedy has expressed plans to overhaul the FDA and reduce the NIH's headco…

1
Pharma and Biotech Daily: Merck's $3 Billion Commitment and Industry Updates 0:54

2h ago0:54

0:54

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Merck has committed up to $3 billion in a deal with Lanova Medicines focused on PD-1/VEGF. The deal comes as Merck faces competition from Bristol Myers Squibb in leukemia, leading Allogene to end phase I enrollment. Analy…

1
#136: Dan Mantz — CEO and Chairman of the Board for the Robotics Education and Competition (REC) Foundation 39:16

4d ago39:16

39:16

It’s fair to say that the robots aren’t coming, they’re already here. Not a week goes by that we don’t see a brand new article about some new self-driving car, another A.I company bursting onto the scene, or full on i-Robot style machines marching down an aisle. It’s hard not to be unnerved by the impact robotics and machine learning can have on th…

1
Pharma and Biotech Daily: Navigating Challenges and Opportunities in the Industry 1:34

9d ago1:34

1:34

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Amgen's obesity candidate, maritide, faced new safety concerns related to bone density, causing a drop in the company's stock. Biogen's shares have also plummeted due to issues such as a slow launch for their Alzheimer's me…

1
Looking Outside Humor: Tom Fishburne, Marketoonist 41:03

9d ago41:03

41:03

On this episode of Looking Outside, we’re exploring the role of humor in business. Whether it’s silly doodles, clever cartoons, or gentle jokes, giving and having the permission to laugh at ourselves, at our industry, and at our field of expertise can elevate corporate culture. Sharing how he does this every day, with over 200 corporate clients, is…

1
Pharma and Biotech Daily: A Recap of the Latest Industry News 0:48

1d ago0:48

0:48

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.AstraZeneca reported strong Q3 sales and raised its 2024 outlook, while avoiding questions about China and announcing plans to invest $2 billion in the U.S. market. Bayer's earnings were described as "not pretty" by CEO Bil…

1
Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals, Inc. 26:10

1d ago26:10

26:10

Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals, Inc.By Court of Appeals for the Federal Circuit

1
VAXXED: Boom or bust? With Chris Kallos and Pitt Street Research 18:30

1d ago18:30

18:30

In some ways, cancer vaccines are a history of hype and hope, over success. But that hasn't stopped people from trying. In 2024, biotech CEOs are hoping that this time, it's different. Research houses are predicting significant market growth come 2030, mRNA vaccines are making it through to phase three clinical trials for the first time, and there …

1
Coppola v. DVA 24:04

13d ago24:04

24:04

Coppola v. DVABy Court of Appeals for the Federal Circuit

1
Pharma and Biotech Daily: Navigating the Ups and Downs of the Industry 0:53

2d ago0:53

0:53

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.AbbVie's shares dropped by 12% after its schizophrenia drug, emraclidine, failed in a phase II trial. This failure has raised concerns about the company's long-term neuroscience strategy. In the Huntington's disease space…

1
The one with Lou Griffiths (EY) 1:09:00

3d ago1:09:00

1:09:00

Welcome to Episode 32 of the Talent Intelligence Collective podcast! Join hosts Alan Walker, Alison Ettridge, and Toby Culshaw as they welcome Lou Griffiths, Senior Manager of Talent Intelligence at EY UK, who shares her remarkable journey in building and scaling talent intelligence capabilities. Toby kicks off with an engaging news segment, coveri…

1
Pharma and Biotech Daily: Eisai's Leqembi Sales Disappoint, Pfizer's $1 Billion Commitment in China, AstraZeneca China Head in Custody, Lilly vs. Novo Dispute, Gene Therapy Webinar, and More 1:04

3d ago1:04

1:04

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Eisai's sales of its Alzheimer's disease therapy Leqembi have disappointed analysts, leading the company to lower its fiscal 2024 guidance. The underwhelming sales are attributed to barriers such as coverage, infusion cen…

1
Maquet Cardiovascular LLC v. Abiomed Inc. 29:43

7d ago29:43

29:43

Maquet Cardiovascular LLC v. Abiomed Inc.By Court of Appeals for the Federal Circuit

1
Phoji, Inc. v. Atlassian US, Inc. 30:58

11d ago30:58

30:58

Phoji, Inc. v. Atlassian US, Inc.By Court of Appeals for the Federal Circuit

1
Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceutica 48:56

7d ago48:56

48:56

Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal PharmaceuticaBy Court of Appeals for the Federal Circuit

1
Ablan v. United States 37:19

17d ago37:19

37:19

Ablan v. United StatesBy Court of Appeals for the Federal Circuit

1
In Re: Secretary of the Army 17:44

7d ago17:44

17:44

In Re: Secretary of the ArmyBy Court of Appeals for the Federal Circuit

1
La Molisana S.p.A. v. United States 29:48

7d ago29:48

29:48

La Molisana S.p.A. v. United StatesBy Court of Appeals for the Federal Circuit

1
Vivint, Inc. v. ADT LLC 23:33

7d ago23:33

23:33

Vivint, Inc. v. ADT LLCBy Court of Appeals for the Federal Circuit

1
Snapshot of the Pharma and Biotech world: Q3 Updates and Industry Insights 0:56

13d ago0:56

0:56

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Moderna exceeded expectations for COVID-19 vaccine sales in the third quarter, but sales of their respiratory syncytial virus vaccine fell short. Gilead also beat expectations in Q3 due to strong sales of their HIV drug.…

1
Advancing Health Care Policies to Meet People's Needs w/ Natalie Davis 42:59

7d ago42:59

42:59

TOPICS (0:16) Intro (1:07) How Natalie Davis Got Started in Health Care (3:25) The Origins of United States of Care (8:00) Where Can We Find Common Ground in Health Care? (14:34) Where Do Policymakers Stand on Medicare for All? (19:00) Are People Paying Attention to Health Care in This Election? (21:08) Is United States of Care an Advocacy Organiza…

1
Pharma and Biotech Daily: Analyzing the Impact of Trump's Win on the Industry 0:55

7d ago0:55

0:55

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Analysts are expressing mixed reactions to Donald Trump's election victory. There are potential positives for the biopharma industry, such as a more friendly FTC for M&A deals. However, concerns have been raised about what…

1
Restem, LLC v. Jadi Cell, LLC 26:14

8d ago26:14

26:14

Restem, LLC v. Jadi Cell, LLCBy Court of Appeals for the Federal Circuit

1
Mid Continent Steel & Wire, Inc. v. United States 34:11

8d ago34:11

34:11

Mid Continent Steel & Wire, Inc. v. United StatesBy Court of Appeals for the Federal Circuit

1
Siples v. McDonough 28:49

18d ago28:49

28:49

Siples v. McDonoughBy Court of Appeals for the Federal Circuit

1
Sierra Wireless, ULC v. Sisvel S.p.A. 50:35

8d ago50:35

50:35

Sierra Wireless, ULC v. Sisvel S.p.A.By Court of Appeals for the Federal Circuit

1
Oman Fasteners, LLC v. United States 38:26

8d ago38:26

38:26

Oman Fasteners, LLC v. United StatesBy Court of Appeals for the Federal Circuit

1
Abutalib v. MSPB 24:51

18d ago24:51

24:51

Abutalib v. MSPBBy Court of Appeals for the Federal Circuit

1
Safe Driving Technologies LLC v. Ford Motor Company 30:42

8d ago30:42

30:42

Safe Driving Technologies LLC v. Ford Motor CompanyBy Court of Appeals for the Federal Circuit

1
BearBox LLC v. Lancium LLC 32:15

8d ago32:15

32:15

BearBox LLC v. Lancium LLCBy Court of Appeals for the Federal Circuit

1
GeoComply Solutions Inc. v. XPoint Services LLC 27:47

9d ago27:47

27:47

GeoComply Solutions Inc. v. XPoint Services LLCBy Court of Appeals for the Federal Circuit

1
Williams v. McDonough 27:40

19d ago27:40

27:40

Williams v. McDonoughBy Court of Appeals for the Federal Circuit

1
Pharma and Biotech Daily: From Gene Editing to Workforce Cuts 0:58

12d ago0:58

0:58

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Beam Therapeutics reported a patient death in a gene editing trial for sickle cell disease, overshadowing otherwise positive data. Beam-101 was found to be competitive with approved treatments, highlighting the need for les…

1
VAXXED: Deadly infection, with Imugene and ImmVirX 23:13

9d ago23:13

23:13

Cancer vaccines are a very niche section of cancer treatments. But two companies in Australia – the only two so far to go public with their work in this arena –are working on an even niche area within this. And one says their work is not a vaccine. The other does. So what gives? Well it depends on what you want to focus on: the deadly infectious na…

1
Pharma and Biotech Daily: Promising Weight Loss Drug, Vaccine Success, and CAR T Therapy for Autoimmune Diseases 0:55

10d ago0:55

0:55

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Viking Therapeutics has reported promising phase I data for their oral weight loss drug, VK2735, with patients on 100-miligram doses losing 8.2% of their body weight after 28 days. Jefferies analyst Roger Song described th…

1
Pharma and Biotech Daily: Top News and Job Opportunities in the Industry 0:47

11d ago0:47

0:47

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novo Nordisk's weight loss drug Wegovy showed significant improvement in liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis in a Phase III trial. Bristol Myers Squibb reported strong third-qu…

1
Pharma and Biotech Daily: Merck, Novo, Amgen, AbbVie, FDA Updates, and More! 0:56

15d ago0:56

0:56

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Merck exceeded Q3 expectations but adjusted its 2024 guidance downwards due to underwhelming revenues from Gardasil and Januvia. Novo is making progress in resolving shortages of Ozempic and Wegovy. Amgen is gearing up for…

1
Pharma and Biotech Daily: Eli Lilly Stock Drops, Biogen Exceeds Expectations, and More Updates 0:45

23d ago0:45

0:45

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Eli Lilly experienced lower-than-expected sales for its weight loss and diabetes drugs in the third quarter, causing its stock to drop by over 13%. Biogen, on the other hand, exceeded expectations for its Alzheimer's drug …

1
The Healthcare Mixtape: CIO & CTO Voices 12:46

15d ago12:46

12:46

In this episode of the Business Resilience Series, Healthcare leaders and CIOs discuss how cutting-edge technologies like AI and Automation along with approaches like Telemedicine are transforming the Healthcare industry. From alleviating administrative burdens to enhancing patient care, these innovations are paving the way for more efficient, inte…

1
Pfizer's Q3 Success and Biopharma Updates: A Daily Dose of Pharma and Biotech News 0:54

16d ago0:54

0:54

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Pfizer exceeded Wall Street's expectations in the third quarter, reporting higher revenue and adjusted profit amid pressure from activist investor Starboard Value. CEO Albert Bourla received a much-needed victory as the …

1
VAXXED: From Gardasil to mRNA, with Dr Ian Frazer and Wilsons Advisory 28:39

21d ago28:39

28:39

Cancer vaccines started out as prevention. Think Gardasil for cervical and oral cancers caused by HPV, and the hepatitis B vaccine for liver cancer. But today the science has moved on, to therapy vaccines. Vaccines that take immune cells and "rub their little noses in the antigen" - the substance that forces the body to sit up and take notice of a …

Podcasts Worth a Listen

Novartis Podcasts

Podcasts Worth a Listen

Quick Reference Guide

zproxy.org